ALX Oncology Exchanges 13.35 Million Shares for Pre-Funded Warrants
ALX Oncology entered separate privately negotiated agreements with key shareholders to exchange 13,353,384 common shares for pre-funded warrants exercisable at $0.001 per share.
ALX Oncology entered separate privately negotiated agreements with key shareholders to exchange 13,353,384 common shares for pre-funded warrants exercisable at $0.001 per share.